Hoffmann & Partner AG

Diese Woche hatten unsere Kollegen Dr. Urs Breitenstein und Simon Marti, CFA die Gelegenheit, im Kurs „Mergers & Acquisitions (M&A) in der Praxis“ an der Fachhochschule Nordwestschweiz FHNW ein Gastreferat zu halten. Gemeinsam mit den Studierenden arbeiteten sie an einer praxisnahen Case Study und teilten wertvolle Einblicke aus der täglichen M&A-Arbeit. Ein herzliches Dankeschön an Dr. Fabian Schmid und die FHNW für die Einladung! Es freut uns sehr, aktiv zur Ausbildung der Studierenden beizutragen. #MergersandAcquisitions #Unternehmensbewertung FHNWbusiness

Wir freuen uns, unsere neue Partnerschaft mit BaseLaunch bekannt zu geben. Durch die Zusammenarbeit mit BaseLaunch wollen wir Unternehmen dabei unterstützen, finanzielle Herausforderungen zu meistern und komplexe Transaktionen erfolgreich umzusetzen.  Wir freuen uns auf eine erfolgreiche Zusammenarbeit 🤝 👉 Lesen Sie mehr: https://lnkd.in/eA6DkUgD Urs Breitenstein, Kaspar Kunz, Thomas P. Wenk, Patrick Schacher #Innovation #LifeSciences #Startups #Partnership #CFOServices We are excited to announce our new partnership with BaseLaunch. Through our collaboration with BaseLaunch, we aim to help companies overcome financial challenges and successfully execute complex transactions. We look forward to a successful partnership 🤝 👉 Read more: https://lnkd.in/ejBKgz4x Urs Breitenstein, Kaspar Kunz, Thomas P. Wenk, Patrick Schacher #Innovation #LifeSciences #Startups #Partnership #CFOServices image: BaseLaunch

We’re pleased to welcome Hoffmann & Partner as our new domain partner. With their strong expertise in mergers & acquisitions (M&A) and CFO services, they're an excellent addition to our collaborative network.    We look forward to a successful partnership.    👉 Read more: https://lnkd.in/eVyEQFtR   Stephan Emmerth, Neil Goldsmith, Martyna Wroblewska, Virginia Ballotta #Innovation #LifeSciences #Startups #Partnership 

Mit Outsourcing und Automatisierung zu zukunftsorientierter Buchhaltung Ein mittelständisches Unternehmen mit 25 Mitarbeitenden hat die Buchhaltung an Hoffmann & Partner ausgelagert, nachdem der langjährige Buchhalter in Pension gegangen war.  In Zusammenarbeit mit dem Kunden und seinen ERP-Partnern wurde innert drei Monaten ein durchgehender Fakturierungsprozess geschaffen, welcher einen Grossteil der Arbeiten automatisiert und die Fehleranfälligkeit reduziert. Die automatisierten Prozesse werden hohen Qualitätsansprüchen gerecht und mit einer Effizienz erledigt, wie sie in der Regel nur mit einer inhouse-Buchhaltung erreicht werden kann. Die Zusammenarbeit zeigt, wie durch Automatisierung und Outsourcing zukunftsorientierte Lösungen entstehen können. Ein gelungenes Beispiel für eine erfolgreiche Partnerschaft. Lesen sie hier den gesamten Case: https://lnkd.in/dzNV47Je #hoffmannpartner #automatisierung #buchhaltung #finanzen

For Dr Thomas Hafen, CEO of the BÜHLMANN Group, the process of selling the company together with Hoffmann & Partner was a central concern in order to successfully initiate the succession of the owners and his succession as CEO. "It was crucial for me that we find the right successors for the company. We have succeeded in doing so. We are satisfied to have found such professional and committed buyers. Hoffmann & Partner's industry knowledge and technical expertise were of great value. The Hoffmann & Partner team provided us with excellent advice throughout the entire transaction." We would like to thank Dr Hafen for his recognition and both parties for their trust and cooperation and of course our team which has been so committed to the project. #hoffmannpartner #mergersandacquisitions #IVD #invitrodiagnostic #nachfolgelösung

For Dr Thomas Hafen, CEO of the BÜHLMANN Group, the process of selling the company together with Hoffmann & Partner was a central concern in order to successfully initiate the succession of the owners and his succession as CEO. "It was crucial for me that we find the right successors for the company. We have succeeded in doing so. We are satisfied to have found such professional and committed buyers. Hoffmann & Partner's industry knowledge and technical expertise were of great value. The Hoffmann & Partner team provided us with excellent advice throughout the entire transaction." We would like to thank Dr Hafen for his recognition and both parties for their trust and cooperation and of course our team which has been so committed to the project. #hoffmannpartner #mergersandacquisitions #IVD #invitrodiagnostic #nachfolgelösung

🔬 Ready to make your mark in the world of biotech? Get inspired by Thomas Baumert, professor of Medicine at the Université de Strasbourg and Inserm, the French National Institute of Health and Medical Research and founder of Alentis Therapeutics, as he shares his journey from lab to business success. Learn his 9 essential tips to turn your research into a viable biotech venture. 👉 Read the article: please find the link in the comment Stephan Emmerth, Neil Goldsmith, Martyna Wroblewska, Virginia Ballotta, Raphaëlle Servant #AccelerateInBasel #Therapeutics #Biotech #Innovation

BÜHLMANN Laboratories AG was sold to KLAR Partners We are pleased to announce that we have successfully accompanied the sale of BÜHLMANN Laboratories AG to KLAR Partners. Since 1976, BÜHLMANN Laboratories AG has been developing and marketing high-quality in-vitro diagnostics and distributing third-party molecular diagnostic products. The company distributes its own products through subsidiaries in Switzerland, Germany, France, Italy, Austria, the USA and Brazil, as well as through more than 60 qualified distributors worldwide. Hoffmann & Partner acted as the exclusive M&A financial advisor to the sellers. We would like to thank both parties for their trust and our team members involved in this project Urs Breitenstein Simon Marti, CFA Claudia Halasz More details on the acquisition: https://lnkd.in/ebwZA5eu #hoffmannpartner #mergersandacquisitions #IVD #invitrodiagnostic #nachfolgelösung

🙌 An inspiring evening on getting started, take a step back, develop, rise and shine as a biotech/medtech company: In their panel discussion, Dr Luca Santarelli, Daniel Geiger and moderator Dani von Wattenwyl gave a glimpse into the everyday life of a listed biotech company and reported first-hand on opportunities, successes and challenges. Many thanks to everyone on the podium, all the guests for sharing the event with us and of course to our team for the great organisation! We invite you to review the evening in the video. #hoffmannpartner #medtech #BiotechInnovation #finance

What an outstanding panel: Thank you for being here on the podium, biotech/medtech experts and entrepreneurs Dr Luca Santarelli, Daniel Geiger and our host and presenter Dani von Wattenwyl. Insightful talks, a lively Q&A session and a reception to round off the evening. Thanks so much to everyone for joining us here in Basel tonight. #hoffmannpartner #medtech #BiotechInnovation #finance